Landmark Bancorp Inc. has made a significant announcement regarding its financial strategy. On October 26, 2026, the company declared a cash dividend of $0.21 per share and a 5% stock dividend. This decision is vital as it showcases the company’s commitment to returning value to its shareholders.
The cash dividend will be paid to all stockholders of record as of the close of business on November 12, 2026, and will be payable on November 27, 2026. Meanwhile, the 5% stock dividend will be issued to stockholders of record as of the close of business on December 2, 2026, and will be issued on December 16, 2026.
Background
Landmark Bancorp Inc. operates in the national commercial banks sector, as classified under the SIC code 6021. The company is listed on the Nasdaq under the ticker symbol LARK. Landmark Bancorp is incorporated in California and has its headquarters in Manhattan, Kansas. The company has been active in filing various reports with the SEC, including its most recent 8-K filings on October 26, 2026.
What the Filing Says
According to the filing, "Landmark Bancorp, Inc. announced on October 26, 2026, that its Board of Directors approved a cash dividend of $0.21 per share and a 5% stock dividend." This statement underscores the company's strategic focus on shareholder value.
Impact
This announcement may positively affect shareholders looking for returns on their investments. By declaring both a cash and stock dividend, Landmark Bancorp signals a robust financial position, which could enhance investor confidence. Additionally, the national commercial banks sector may view this as a positive trend, potentially influencing other banks to consider similar actions.
What's Next
The filing does not say what happens next. However, shareholders can expect the dividends to be distributed as per the announced schedule.
Read Next
Azenta CFO Lin Lawrence Y. Reports Stock Transactions
Florek acquires 2,510 deferred stock units in McEwen Inc.
CFO Ing Perry acquires restricted stock units at McEwen Inc.
Saba Capital Management increases stake in BNY Mellon fund
Kura Oncology CEO Troy Wilson Acquires Over 200,000 Shares
Saba Capital Management Reports New Stock Acquisitions






